← Zurück zu Insidertransaktionen
RA Capital Management, L.P.
Gemeldet als: RA CAPITAL MANAGEMENT, L.P.
Insider · 10% Owner / Director / 10% Owner
Käufe
28
71.179.662 USD
Verkäufe
22
94.999.748 USD
Unternehmen
8
mit gemeldeten Geschäften
Letzte Aktivität
02.11.2026
50 Transaktionen gesamt
| Datum | Unternehmen | Position | Art | Volumen | Preis | Stückzahl | Seit Meldung |
|---|---|---|---|---|---|---|---|
| 02.11.2026 |
Bambusa Therapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 2.638.256,00 USD | 16,00 USD | 164.891 | – |
| 02.11.2026 |
Bambusa Therapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 37.361.744,00 USD | 16,00 USD | 2.335.109 | – |
| 30.10.2026 |
Bambusa Therapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 3.937.552,12 USD | 14,92 USD | 263.911 | – |
| 30.10.2026 |
Bambusa Therapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 2.702.405,07 USD | 14,23 USD | 189.909 | – |
| 29.10.2026 |
Lenz Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 360.091,20 USD | 3,36 USD | 107.170 | – |
| 29.10.2026 |
Lenz Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 1.518.713,28 USD | 3,36 USD | 451.998 | – |
| 29.10.2026 |
Lenz Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 7.255.973,76 USD | 3,36 USD | 2.159.516 | – |
| 17.09.2026 |
Sionna Therapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Verkauf | 252.148,00 USD | 7,46 USD | 33.800 | – |
| 17.09.2026 |
Sionna Therapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Verkauf | 21.582.869,52 USD | 6,32 USD | 3.415.011 | – |
| 12.08.2026 |
Septerna, Inc.
Director / 10% Owner
|
Director / 10% Owner | Verkauf | 31.726.250,00 USD | 42,50 USD | 746.500 | – |
| 12.08.2026 |
Septerna, Inc.
Director / 10% Owner
|
Director / 10% Owner | Verkauf | 31.726.250,00 USD | 42,50 USD | 746.500 | – |
| 31.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 247.693,92 USD | 9,93 USD | 24.944 | – |
| 29.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 208.031,76 USD | 9,99 USD | 20.824 | – |
| 24.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 412.776,81 USD | 9,99 USD | 41.319 | – |
| 23.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 596.404,80 USD | 9,96 USD | 59.880 | – |
| 22.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 835.351,32 USD | 9,93 USD | 84.124 | – |
| 22.07.2026 |
Parabilis Medicines, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 1.406.632,50 USD | 29,77 USD | 47.250 | – |
| 21.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 1.151.558,10 USD | 9,55 USD | 120.582 | – |
| 21.07.2026 |
Parabilis Medicines, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 1.131.690,00 USD | 30,00 USD | 37.723 | – |
| 21.07.2026 |
Parabilis Medicines, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 189.721,68 USD | 29,17 USD | 6.504 | – |
| 21.07.2026 |
Parabilis Medicines, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 606.620,16 USD | 27,96 USD | 21.696 | – |
| 20.07.2026 |
Parabilis Medicines, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 914.399,64 USD | 27,72 USD | 32.987 | – |
| 20.07.2026 |
Parabilis Medicines, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 2.670.487,29 USD | 27,13 USD | 98.433 | – |
| 17.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 70.543,90 USD | 8,95 USD | 7.882 | – |
| 16.07.2026 |
VOR Biopharma Inc.
10% Owner
|
10% Owner | Verkauf | 4.206,75 USD | 19,75 USD | 213 | – |
| 16.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 1.361.574,96 USD | 8,93 USD | 152.472 | – |
| 13.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 58.574,88 USD | 8,94 USD | 6.552 | – |
| 10.07.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 135.464,94 USD | 8,97 USD | 15.102 | – |
| 26.06.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 16.846,48 USD | 8,98 USD | 1.876 | – |
| 25.06.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 275.280,00 USD | 8,88 USD | 31.000 | – |
| 17.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 9.693,25 USD | 0,35 USD | 27.695 | – |
| 17.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 136.225,60 USD | 0,35 USD | 389.216 | – |
| 16.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 3.677,43 USD | 0,37 USD | 9.939 | – |
| 16.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 51.683,82 USD | 0,37 USD | 139.686 | – |
| 16.06.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 1.110.298,77 USD | 8,89 USD | 124.893 | – |
| 15.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 3.336,06 USD | 0,39 USD | 8.554 | – |
| 15.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 46.884,24 USD | 0,39 USD | 120.216 | – |
| 15.06.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 138.571,86 USD | 8,99 USD | 15.414 | – |
| 12.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 4.528,80 USD | 0,40 USD | 11.322 | – |
| 12.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 63.647,60 USD | 0,40 USD | 159.119 | – |
| 12.06.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 3.351.032,83 USD | 8,57 USD | 391.019 | – |
| 11.06.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 4.339.267,80 USD | 7,91 USD | 548.580 | – |
| 11.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 6.626,06 USD | 0,38 USD | 17.437 | – |
| 11.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 93.125,08 USD | 0,38 USD | 245.066 | – |
| 10.06.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 721,00 USD | 7,00 USD | 103 | – |
| 10.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 1.128,87 USD | 0,37 USD | 3.051 | – |
| 10.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 15.862,64 USD | 0,37 USD | 42.872 | – |
| 09.06.2026 |
Artiva Biotherapeutics, Inc.
Director / 10% Owner
|
Director / 10% Owner | Kauf | 3.310.159,49 USD | 6,91 USD | 479.039 | – |
| 09.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 9.089,05 USD | 0,37 USD | 24.565 | – |
| 09.06.2026 |
Werewolf Therapeutics, Inc.
10% Owner
|
10% Owner | Verkauf | 127.736,95 USD | 0,37 USD | 345.235 | – |
Alle von „RA CAPITAL MANAGEMENT, L.P." gemeldeten Eigengeschäfte (Directors' Dealings) gemäß Art. 19 MAR bzw. den jeweiligen nationalen Pflichtmeldungen. Gleiche Personen können unter abweichenden Schreibweisen mehrfach geführt sein. „Seit Meldung" vergleicht den aktuellen Kurs (deutsche Handelsplätze, EUR) mit dem gemeldeten EUR-Preis der Transaktion — Meldungen in anderen Währungen bleiben ohne Angabe. Details in der Methodik.